Virpax Pharmaceuticals, Inc.
VRPX
Revenue
0.00
0.000.00%
-Assets
2.59M
▼-539.80k▼-17.24%
3 Months ChangeLiabilities
5.39M
▲1.04M▲23.97%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-07
Form 8-K
ID: 0001731122-24-001548
2024-10-04
Form 8-K
ID: 0001731122-24-001543
2024-10-03
Form 8-K
ID: 0001731122-24-001539
2024-10-03
Form 8-K
ID: 0001731122-24-001537
2024-09-25
Form 8-K
ID: 0001731122-24-001482
2024-09-17
Form 8-K
ID: 0001731122-24-001427
2024-08-13
Form 8-K
ID: 0001213900-24-067908
2024-08-12
Form 10-Q
ID: 0001213900-24-067700
2024-07-30
Form 8-K
ID: 0001013762-24-002775
2024-07-26
Form 8-K
ID: 0001013762-24-001638